Harmen Beurmanjer

112 References McDaniel, C. H., & Miotto, K. A. (2001). Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: Five case studies. Journal of Psychoactive Drugs , 33 (2), 143–149. https://doi.org/10.1080/02791072.2001.10400479 McDonough, M., Kennedy, N., Glasper, A., & Bearn, J. (2004). Clinical features and management of gamma-hydroxy- butyrate (GHB) withdrawal: A review. Drug and Alcohol Dependence , 75 (1), 3–9. https://doi.org/10.1016/j. drugalcdep.2004.01.012 McKay, J. R. (2017). Making the hard work of recovery more attractive for those with substance use disorders. Addiction , 112 (5), 751–757. https://doi.org/10.1111/add.13502 McLellan, A. T., Lewis, D. C., O’Brien, C. P., & Kleber, H. D. (2000). Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA , 284 (13), 1689–1695. https://doi.org/ jsc00024 [pii] Miotto, K., Darakjian, J., Basch, J., Murray, S., Zogg, J., & Rawson, R. (2001). Gamma-hydroxybutyric acid: Patterns of use, effects andwithdrawal. AmericanJournalonAddictions , 10 (3), 232–241. https://doi.org/10.1080/105504901750532111 Miotto, Karen, & Roth, B. (2001). GHB withdrawal syndrome. In Substance Abuse . Mirijello, A., Caputo, F., Vassallo, G., Rolland, B., Tarli, C., Gasbarrini, A., & Addolorato, G. (2015). Gaba<inf>B</inf> agonists for the treatment of alcohol use disorder. Current Pharmaceutical Design , 21 (23), 3367–3372. Mol, T., Wisselink, J., Kuijpers, W., & Dijkstra, B. (2014). GHB: recidive op eenzame hoogte. Verslaving , 10 (3), 69–79. https://doi.org/10.1007/s12501-014-0030-6 Moss-Morris, R., Weinman, J., Petrie, K., Horne, R., Cameron, L., & Buick, D. (2002). The revised Illness Perception Questionnaire (IPQ-R). Psychology and Health , 17 (1), 1–16. https://doi.org/10.1080/08870440290001494 Muller, C. A., Geisel, O., Pelz, P., Higl, V., Kruger, J., Stickel, A., … Heinz, A. (2015). High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial. European Neuropsychophar- macology , 25 (8), 1167–1177. https://doi.org/10.1016/j.euroneuro.2015.04.002 Nasreddine Z. (2005). MoCA: a Brief Screening Tool for Mild Cognitive Impairment. In The Montreal Cognitive Assessment (Vol. 53). Neu, P. (2018). Verlauf und Komplikationen des GHB-Entzuges: eine 1‑Jahres-Fallserie. Der Nervenarzt . https://doi. org/10.1007/s00115-018-0636-8 Neu, P., Sofin, Y., & Danker-Hopfe, H. (2018). The Effect of Detoxification on Sleep: How Does Sleep Quality Change during Qualified Detoxification Treatment? Journal of Addiction . https://doi.org/10.1155/2018/9492453 Nicholson, K. L., & Balster, R. L. (2001). GHB: A new and novel drug of abuse. Drug and Alcohol Dependence , Vol. 63, pp. 1–22. https://doi.org/10.1016/S0376-8716( 00)00191-5 Nijkamp, L. (2019). Bezieling en bereikbaarheid. Samen werken aan een leven zonder GHB. Een handreiking voor Nederlandse gemeente ten behoeve van de aanpak van GHB-problematiek . Utrecht. Palamar, J. J., & Halkitis, P. N. (2006). A qualitative analysis of GHB use among gay men: Reasons for use despite potential adverse outcomes. International Journal of Drug Policy . https://doi.org/10.1016/j.drugpo.2005.11.002 Phan, V., Arunogiri, S., & Lubman, D. I. (2020). The assessment and management of gamma hydroxybutyrate use in general practice. Australian Journal of General Practice . https://doi.org/10.31128/AJGP-05-19-4953 Ramchand, R., Fisher, M. P., Griffin, B. A., Becker, K., & Iguchi, M. Y. (2013). Drug use among gay and bisexual men at weekend dance parties: The role of intentions and perceptions of peers’ behaviors. AIDS and Behavior , 17 (4), 1540–1549. https://doi.org/10.1007/s10461-012-0382-z Raposo Pereira, F., McMaster, M. T. B., Polderman, N., de Vries, Y. D. A. T., van den Brink, W., & van Wingen, G. A. (2018a). Adverse effects of GHB-induced coma on long-term memory and related brain function. Drug and Alcohol Dependence , 190 , 29–36. https://doi.org/10.1016/j.drugalcdep.2018.05.019 Raposo Pereira, F., McMaster, M. T., Polderman, N., DAT de Vries, Y., van den Brink, W., & van Wingen, G. A. (2018). Effect of GHB-use and GHB-induced comas on dorsolateral prefrontal cortex functioning in humans. NeuroImage: Clinical . https://doi.org/10.1016/j.nicl.2018.09.022 Rensen, Y. C. M., Egger, J. I. M., Westhoff, J., Walvoort, S. J. W., & Kessels, R. P. C. (2019). Errorless (re)learning of everyday activities in patients with Korsakoff’s syndrome: A feasibility study. Neuropsychological Rehabilitation . https:// doi.org/10.1080/09602011.2017.1379419 Rolland, B., Jaillette, E., Carton, L., Bence, C., Deheul, S., Saulnier, F., … Cottencin, O. (2014). Assessing Alcohol Versus Baclofen Withdrawal Syndrome in Patients Treated With Baclofen for Alcohol Use Disorder. Journal of Clinical Psychopharmacology , 34 (1), 153–156. https://doi.org/10.1097/JCP.0000000000000054